| Related LncRNAs | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| ID | lncRNA Name | Disease | Method | Sample | Expression pattern | Dysfunction type | Description | PMID | Source |
| EL0578 | HOTAIR | non-functioning pituitary adenoma | microarray, qPCR etc. | NFPA tissue | up-regulated | expression | Expression of the long non-coding RNAs MEG3, HOTAIR, and MALAT-1 in non-functioning pituitary adenomas and their relationship to tumor behavior. | 24469926 | LncRNADisease Lnc2Cancer |
| EL0861 | MEG3 | non-functioning pituitary adenoma | inducible and constitutively active expression systems | PDFS cells derived from a human NFA (non-functioning pituitary adenomas) | up-regulated | expression | MEG3 expression significantly suppressed xenograft tumor growth in vivo in nude mice. When induced in culture, MEG3 caused cell cycle arrest at the G1 phase. | 26284494 | |
| EL0861 | MEG3 | non-functioning pituitary adenoma | microarray, qPCR etc. | NFPA tissue | down-regulated | N/A | qPCR analyses showed that MEG3 expression was lost in 32 of 52 NFPAs (61.5 %). In addition, MEG3 lncRNA levels were significantly decreased in invasive NFPAs and non-invasive NFPAs compared to normal anterior pituitaries. Furthermore, MEG3 expression was significantly decreased in invasive NFPAs compared to non-invasive NFPAs. | 24469926 | LncRNADisease Lnc2Cancer |
| EL0861 | MEG3 | non-functioning pituitary adenoma | qPCR etc. | pituitary tumor tissue | down-regulated | epigenetics | Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors. | 15644399 | LncRNADisease Lnc2Cancer |
| EL0861 | MEG3 | non-functioning pituitary adenoma | qPCR etc. | pituitary tumor tissue | down-regulated | expression | Maternally Expressed Gene 3 (MEG3), which is specifically associated with clinically non-functioning pituitary adenomas of a gonadotroph lineage. | 20211686 | LncRNADisease Lnc2Cancer |
| EL0861 | MEG3 | non-functioning pituitary adenoma | qPCR etc. | pituitary adenoma tissue | down-regulated | expression | The DLK1-MEG3 locus is silenced in NFAs (nonfunctioning adenomas). The DLK1-MEG3 locus plays a tumor suppressor role in human NFAs. | 21871428 | LncRNADisease Lnc2Cancer |
| EL0861 | MEG3 | non-functioning pituitary adenoma | qPCR, ISH etc. | pituitary tumor tissue | down-regulated | epigenetics | Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas. | 18628527 | LncRNADisease Lnc2Cancer |
| EL0862 | Meg3 | non-functioning pituitary adenoma | Quantitative RT-PCR immunohistological | Meg3 knockout mice | up-regulated | expression | Meg3 may play an important role in control of vascularization in the brain and may function as a tumor suppressor in part by inhibiting angiogenesis | 20392836 | |